 CHATHAM, N.J., June 16, 2021 GLOBE NEWSWIRE -- Tonix Pharmaceuticals Holding Corp. Nasdaq: TNXP Tonix or the Company, a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will present at the Raymond James Human Health Innovation Conference on June 23, 2021, at 8:00 a.m. ET. 